| Product Code: ETC7635988 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Oncology Based Molecular Diagnostics Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Oncology Based Molecular Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Oncology Based Molecular Diagnostics Market - Industry Life Cycle |
3.4 Ireland Oncology Based Molecular Diagnostics Market - Porter's Five Forces |
3.5 Ireland Oncology Based Molecular Diagnostics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Ireland Oncology Based Molecular Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Ireland Oncology Based Molecular Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F |
4 Ireland Oncology Based Molecular Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Ireland |
4.2.2 Growing demand for personalized medicine in oncology |
4.2.3 Technological advancements in molecular diagnostics |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for diagnostic tests |
4.3.2 High cost associated with molecular diagnostic tests |
4.3.3 Limited reimbursement policies for molecular diagnostics in Ireland |
5 Ireland Oncology Based Molecular Diagnostics Market Trends |
6 Ireland Oncology Based Molecular Diagnostics Market, By Types |
6.1 Ireland Oncology Based Molecular Diagnostics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Oncology Based Molecular Diagnostics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Ireland Oncology Based Molecular Diagnostics Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.1.4 Ireland Oncology Based Molecular Diagnostics Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.1.5 Ireland Oncology Based Molecular Diagnostics Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.1.6 Ireland Oncology Based Molecular Diagnostics Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.1.7 Ireland Oncology Based Molecular Diagnostics Market Revenues & Volume, By Liver Cancer, 2021- 2031F |
6.1.8 Ireland Oncology Based Molecular Diagnostics Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.1.9 Ireland Oncology Based Molecular Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Ireland Oncology Based Molecular Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Ireland Oncology Based Molecular Diagnostics Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Ireland Oncology Based Molecular Diagnostics Market Revenues & Volume, By PCR, 2021- 2031F |
6.2.3 Ireland Oncology Based Molecular Diagnostics Market Revenues & Volume, By In situ hybridization, 2021- 2031F |
6.2.4 Ireland Oncology Based Molecular Diagnostics Market Revenues & Volume, By INAAT, 2021- 2031F |
6.2.5 Ireland Oncology Based Molecular Diagnostics Market Revenues & Volume, By Chips and microarrays, 2021- 2031F |
6.2.6 Ireland Oncology Based Molecular Diagnostics Market Revenues & Volume, By Mass spectrometry, 2021- 2031F |
6.2.7 Ireland Oncology Based Molecular Diagnostics Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.2.8 Ireland Oncology Based Molecular Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.2.9 Ireland Oncology Based Molecular Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Ireland Oncology Based Molecular Diagnostics Market, By Product |
6.3.1 Overview and Analysis |
6.3.2 Ireland Oncology Based Molecular Diagnostics Market Revenues & Volume, By Instruments, 2021- 2031F |
6.3.3 Ireland Oncology Based Molecular Diagnostics Market Revenues & Volume, By Reagents, 2021- 2031F |
6.3.4 Ireland Oncology Based Molecular Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Oncology Based Molecular Diagnostics Market Import-Export Trade Statistics |
7.1 Ireland Oncology Based Molecular Diagnostics Market Export to Major Countries |
7.2 Ireland Oncology Based Molecular Diagnostics Market Imports from Major Countries |
8 Ireland Oncology Based Molecular Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of molecular diagnostics in oncology |
8.2 Number of clinical trials incorporating molecular diagnostics |
8.3 Rate of approval for new molecular diagnostic technologies |
9 Ireland Oncology Based Molecular Diagnostics Market - Opportunity Assessment |
9.1 Ireland Oncology Based Molecular Diagnostics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Ireland Oncology Based Molecular Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Ireland Oncology Based Molecular Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F |
10 Ireland Oncology Based Molecular Diagnostics Market - Competitive Landscape |
10.1 Ireland Oncology Based Molecular Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Ireland Oncology Based Molecular Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here